2024-07-1920514.63 KB4页9
2024-07-192053.47 MB1页27
2024-07-192051.64 MB25页17
2024-07-192051.34 MB25页21
2024-07-19205582.62 KB18页7
2024-07-19205398.73 KB21页9
2024-07-192057.14 MB63页25
2024-07-19205877 KB79页2
2024-07-1920513.34 MB111页27
2024-07-19205687.11 KB13页18
2024-07-19205231.14 KB8页16
2024-07-152054.78 MB41页3
2024-07-15205673.46 KB18页25
2024-07-1920523.53 KB50页17
2024-07-17205159.89 KB2页22
“中国新靶点”数据分析赋能未满足临床需求药物研发王中健博士享融智云CEOhttps://www.pharnexcloud.com/目录CONTENTS01新药研发现状及热门靶点概述02深入挖掘“中国新靶点”03各适应症“中国新靶点”分析04总结https://www.pharnexcloud.com/全球新药数量分阶段统计124,521国内首家研发企业43,909国外首家研发企业80,61215,5905,0224,9266,1163,0271,413774787药物发现12,5634,1521,6155,329334临床前4604723,609II期临床1,281... 2024-07-172058.18 MB31页24
EshStatementEuropeanSocietyofHypertensionpositionpaperonrenaldenervation2018RolandE.Schmiedera,FelixMahfoudb,MichelAzizic,d,AtulPathake,KyriakosDimitriadisf,AbrahamA.Kroong,ChristianOtta,h,FilippoScalisei,GiuseppeManciaj,andCostasTsioufisk,onbehalfofMembersoftheESHWorkingGrouponInterventionalTreatmentofHypertensionThisESHupdatewasdeemednecessarywiththeBACKGROUNDpublicationofnewresultsofsham-con... 2024-07-25204324.48 KB7页18
2024-07-25204366.65 KB1页7
2024-07-242041.69 MB18页25
2024-07-2220411.04 MB58页16